Performance of bioprostheses and mechanical protheses assessed by composites of valve-related complications at 15 years for aortic valve replacement  by Jamieson, W.R.Eric et al.
5 16A ABSTRACTS - Valvular Heart Disease 
4:15 p.m. 
859-2 Echocardiographic Predictors of Aortic Valve Repair in 
Patients With Bicuspid Valves and Aorlic Regurgitation 
Patrick J. Nash, Eugene Vitvitsky, Delos M. Cosgrove, III, Gosta Pettersson, Richard A. 
Grimm, The Cleveland Clinic Foundation, Cleveland, OH 
Background: There is increasing interest in valve sparing operations for patients with 
isolated severe aortic regurgitation (AR). Bicuspid valves are recognized as most suit- 
able for repair. Echocardiographic features that predict successful repair within this spe- 
cific population, are not well defined. 
Methods: We reviewed all intraoperative transesophageal ethos performed on patients 
with isolated moderate/severe AR and bicuspid valves undergoing surgery at our institu- 
tion (67 patients; mean age 41.3 +I- 12.5 yrs.; range 19-77: 92% male), over a two-year 
period (2000-20023. Results: Valve repair was performed I” 53 patients (60.9%). An 
additional 13 patients (14.9%) had failed repairs requiring valve replacement. Patients 
undergoing repair were significantly younger than those having a replacement. Repair 
was more likely when the anatomy was typical with left coronary/right coronary cusp 
fusion end when the primary mechanism of AR was leaflet prolapse or commissural sep- 
aration, compared with poor leaflet coaptationl “central defect”. Other parameters associ- 
ated with successful repair were less ascending aortic dilatation, less prominent raphe, 
less leaflet edge or commissural thickening/calcification. Conclusions A number of 
echo features predict valve repairability in patients with bicuspid aortic valves and iso- 
lated AR. These include leaflet anatomy, aortic diameter, primary mechanism of regurgi- 
tation, and leaflet, raphe and commissural thickening/calcification. 
ReDair Replacement 
(vrs) Aqe 
Aorta (cm) 
Mid Ascending 
36+/-IO 49+/-11 
3.56 4.00 
p < 0.001 
p = 0.04 
Mechanism: % 
Leaflet Prolapse 
69.6 41.1 p = 0.03 
Mechanism: (%) 9.4 23.5 p = 0.05 
Poor Leaflet Coaptation/“Centrai Defect” 
Atvpicai Anatomy: (% 
Non Left/Right Cusp Fusion 
9.4 26.4 p = 0.07 
Leaflet Edge Thickness 
> 0.3mm (76) 
11.3 32.3 p = 0.01 
Commissurai Thickenino (% 18.8 35.3 p=o.O4 
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859-3 Performance of Bioprostheses and Mechanical 
Prostheses Assessed by Composites of Valve-Related 
Complications at 15 Years for Aortic Valve Replacement 
W. R. Eric Jamieso$ Olga van Llpinski, Eva Germann. Robert T. Miyagishima. Lawrence 
H. Burr, Michael T. Janusz. Hilton Ling, Guy Fradet. University of British Columbia, 
Vancouver, BC, Canada 
Background: Long-term periormance of prostheses-type for patients requiring aortic 
valve replacement (AVR) requires complete assessment to facilitate choice. 
Methods: AVR was performed in 2,191 bioprostheses (BP) and 975 mechanical prosthe- 
ses (MP) since 1962. Cumulative follow-up for BP was 14,522 patient-years and MP, 
5,972 patient-years. Freedom from composites of valve-related (VR) complications - VR 
reoperation (REOP), VR morbidity (MORB-permanent impairment) and VR mortality 
(MORT) by age groups (~40, 41-50, 51-60,61-70, >70 years) and predictive riik factors 
were determined. CompTcations in patients who experienced reoperations were attrib- 
uted to prosthesis types. 
Results: The linearized occurrence rates (% per patient year) for composites of compli- 
cations were: overall- VR REOP BP 1.2, MP 0.3 p<O.Ol; VR MORB BP 0.5, MP 0.6 pNS; 
VR MORT BP 0.9, MP 0.5 p=O.O14 and for >70 years VR REOP BP 0.3, MP 0 pNS, VR 
MORB BP 0.7, MP 0.6 pNS, VR MORT BP 1.3, MP 0.6 pNS. Predictors of VR REOP 
were age (OR 0.95, peO.OOl), valve type (OR 6.1, pcO.001). and concomitant coronary 
artery bypass (OR 1.6, p=O.O312): of VR MORTwere age (OR 1.04, p<O.OOi), valve type 
(OR 1.1, pNS); no concomitant CAB (OR 1.3, pNS); and VR MORB were age (OR 1.05, 
p<O.OOl) and male gender (OR 1.5, p&O49 - marginal). Actual freedom from compos- 
ites of all VR complications was determined for all categories at 15 years. The z.70 years 
freedom for VR REOP is 97.7+0.7% BP, 100% MP: for VR MORB 94.5+0.9% BP. 94.9 
+ 2.2% (12 years) MP; for VR MOAT 66.92 1.6% BP, 94.6 i 2.3% (12 years) MP. 
Conclusions: Freedom from VR REOP was unacceptable, at 15 years, for BP age 
groups ( 60 years (intermediate 61-70, 90.2+ t .9%, and acceptable >70. 97.7+0.7%). 
Freedom from VR MORB (permanent impairment) was extended for all age groups for 
BP and MP. Freedom from VR MORT increased for all age groups for MP, yet BP 
reduced all age groups. Chronicity of care, risk of non-morbid thromboembolic events 
and hemorrhagic events would be influential factors to avoid MP over 61.70 years and 
especially >70 years. 
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859-4 The Risks and Benefits of Reoperation Aortic Valve 
Replacement 
Vincent A. Gaudiani, Luis J. Castro, Gary J. Grunkemeier, Audrey L. Fisher, YingXing 
Wu, Salim Aziz, Sequoia Hospital, Redwood City, CA 
The Risks and Benefits of Re-operation Aorlic Valve Replacement 
Background: Many patients are advised to have mechanical aortic valve replacement 
(AVR) because their expected longevity exceeds that of tissue prostheses. This strategy 
may avoid the risks of re-operation, but exposes patients to the risks of long-term antico- 
agulation. Which risk is greater? 
Methods: We reviewed the records of 1213 consecutive, unselected AVR patients, of 
whom 60% had concomitant procedures, treated from 1994 -2002. Of these, 326 had at 
least one previous median sternotomy, and in 134, a previous operation included AVR or 
aortic root reconstruction. We constructed a risk model from the 1213 cases to assess 
factors that predicted mortality and to examine the extent to which w-operation effects 
outcome. 
Results The Table shows the factors that predicted mortality by multiple logistic regres- 
sion analysis and the associated odds ratios. In this series, w-operation did not predict 
mortality. In fact mortality for all first AVR was 4.1% and for all re-operation AVR was 
3.1% (p=O.891). 
Risk Factor p-value OR 
Preop Dialysis 0.004 6.606 
Preop Cardiogenic Shock 0.001 4.941 
NYHA Class IV 0.070 1.931 
Female 0.071 1.852 
Perfusion Time 0.005 1.114 
Age 0.023 1.044 
Conclusions: In this series the risk of r&!-operation AVR is lower than the published risks 
of coumadin administration after mechanical AVR. Any adult who requires AVR may be 
well advised to consider tissue prostheses. 
